Identifying which bacteria or viruses have caused an infection is not straightforward with current methods. It takes several tests and several days, which in the context of hospitalized patients means it's both expensive and slow. PathoQuest enables screening for more than 1200 pathogens with a single test instead of several. Patented blood sample preparation combined with bioinformatic processing and matching of results against a proprietary database make this breakthrough in diagnostics possible. PathoQuest's CE-marked test significantly reduces the problematic use of broad-spectrum antibiotics. It is the major cause of antibiotic resistance, a growing danger to public health. PathoQuest scientific base is research by Prof. Marc Eloit, a world-leading virologist at Pasteur Institute in Paris.
Location: France, Ile-de-France, Paris
Employees: 11-50
Total raised: $13.79M
Founded date: 2010
Investors 6
| Date | Name | Website |
| - | Verve Vent... | verve.vc |
| - | Idinvest P... | idinvest.c... |
| - | Kurma Part... | kurmapartn... |
| 21.03.2022 | Turenne Ca... | turennecap... |
| - | Fraser Fin... | fraserfina... |
| 23.11.2021 | SHS Gesell... | shs-capita... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 05.09.2019 | - | $8.83M | - |
| 15.07.2013 | - | $4.96M | - |
Mentions in press and media 5
| Date | Title | Description |
| 05.02.2024 | Is Biotechnology Revolutionizing Pathogen Detection in Europe’s Healthcare Industry? | Key Takeaways: PathoQuest is a Paris-based startup focusing on improving pathogen detection through using a metagenomics approach. This next-generation sequencing (NGS) based testing approach offers exhaustive identification of pathogens, o... |
| 24.11.2021 | PathoQuest Receives GMP Certification for Its NGS-based Quality Control Testing Services of Biological Drugs | PathoQuest, a leading contract research organization (CRO) for the biosafety testing of biologics with Next-Generation Sequencing (NGS) technologies, today announced that it has obtained a Good Manufacturing Practices (GMP) certificate for ... |
| 05.09.2019 | Daily funding roundup - September 5th, 2019 | CrowdBureau raised $1.1M; DappRadar picks up $2.33M; Upflow landed $2.7M; Saltbox closed $3.2M CrowdBureau: CrowdBureau is an information technology platform that offers asset and risk management tools. CrowdBureau has raised $1.1 million i... |
| 05.09.2019 | PathoQuest Secures €8M in Financing | PathoQuest, a Paris, France-based genomic expert company, closed an €8M financing. The funding includes a venture loan from Norgine Ventures, financing from historical investors Kurma Partners, Idinvest Partners and strategic partner, Charl... |
| 15.07.2013 | PathoQuest Raises $4.96M in Funding | PathoQuest, a Paris, France-based molecular diagnostics company, raised about $4.96m in funding. Backers included new investors Idinvest and Aurinvest, and existing investor Kurma Life Science Partners. Founded in 2010 as a spin-off of the ... |